Doctolib - Your health partner vs MyChart

MyChart earns about $0 per month, while Doctolib - Your health partner earns about $0. That is a ∞× revenue gap. Annual revenue: Doctolib - Your health partner ≈ $0/year, MyChart ≈ $0/year. Estimates are derived from public App Store signals - grossing rank, scraped IAP tiers, ratings and category benchmarks.

MyChart leads with about 97.1M estimated downloads vs 49K for Doctolib - Your health partner - a 1972.0× gap. Doctolib - Your health partner's App Store downloads are estimated from 985 ratings × the standard 1:75 ratio. MyChart's App Store downloads are estimated from 647K ratings.

Yes - both apps sit in the Medical category, which means they compete directly for the same paying users and category-level wallet share. Direct competitors, head-to-head.

Doctolib - Your health partner does not appear to offer in-app purchases on its public listing. MyChart does not appear to offer in-app purchases. Monetization model: Doctolib - Your health partner runs "No App Store revenue (monetizes off-store)", MyChart runs "No App Store revenue (monetizes off-store)".

Doctolib - Your health partner edges ahead with ★ 4.7 vs ★ 4.6 (gap of 0.1 stars). Rating volume: Doctolib - Your health partner 985 ratings, MyChart 647K ratings. Higher rating volume = stronger ASO signal even when star averages are close.

Directional - typically within 2-3× of actual money earned for popular apps. The $0 for Doctolib - Your health partner and $0 for MyChart are derived from App Store grossing rank, scraped IAP tiers, ratings volume and category benchmarks (Medical) - net of the 15-30% Apple/Google store cut. Real revenue depends on country mix, retention, refunds and ad fill rate, none of which Apple or Google publish.

Use the search box at the bottom of this page or paste any two App Store links into the homepage tool. We auto-generate a permanent comparison URL with revenue, downloads, IAP tiers, subscription pricing and grossing rank for both apps.